7 results
IDSA - Prophylaxis to Prevent First Episode of Opportunistic Disease in HIV-AIDS
 • Pneumocystis pneumonia (PCP)
IDSA - Prophylaxis ... A and B virus infection ... #OIs #HIVAIDS # ... IDSA #management ... #pharmacology
IDSA - Prophylaxis to Prevent First Episode of Opportunistic Disease in HIV-AIDS
 • Pneumocystis pneumonia (PCP)
IDSA - Prophylaxis ... A and B virus infection ... #OIs #HIVAIDS # ... IDSA #management ... #pharmacology
IDSA Recommendations for Preventing and Treating Bacterial Enteric Infections in HIV-AIDS
Preventing Bacterial Enteric Illness:
 • Antimicrobial
Bacterial Enteric Infections ... Antimicrobial prophylaxis ... against Pneumocystis pneumonia ... Prevention #Treatment #management ... #HIVAIDS #pharmacology
Differentiation Syndrome in APML
Epidemiology:
 • Incidence: common in APL (2-48% depending on the study)
 • Triggers:
endothelial damage Prophylaxis ... Imaging: CXR- pulmonary ... initiation • Differential ... Diagnosis: Infection ... APML #diagnosis #management
IDSA Recommendations for Treating Coccidiodomycosis in HIV-AIDS
Treating Mild Infections (Such As Focal Pneumonia or asymptomatic patients
Treating Mild Infections ... (Such As Focal Pneumonia ... (Diffuse Pulmonary ... Prevention #Treatment #management ... #HIVAIDS #pharmacology
Immune Reconstitution Inflammatory Syndrome - Overview of IRIS

What Is IRIS?
	• A state of hyperinflammatory response that
Lymphadenitis, pulmonary ... cryptococcomas, cavitating pneumonia ... Leishmaniasis Differential ... Inflammatory #Syndrome #Differential ... #Diagnosis #Management
IDSA Recommendations for Prevention and Treatment of Pneumocystis Pneumonia (PCP) in HIV-AIDS
Indications for Initiating Primary Prophylaxis:
of Pneumocystis Pneumonia ... #Pneumocystis #Pneumonia ... opportunistic #infections ... #HIVAIDS #management ... #pharmacology